Cargando…
Carcinovic cohort: prognostic factors of death in HIV/HCV coinfected patients with hepatocellular carcinoma (HCC)
Autores principales: | Gelu-Simeon, M, Lewin, M, Sobesky, R, Ostos, M, Bayan, T, Boufassa, F, Meyer, L, Persoz, A, Teicher, E, Fontaine, H, Salmon-Céron, D, Seror, O, Trinchet, J-C, Duclos-Vallée, J-C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220859/ http://dx.doi.org/10.1186/1471-2334-14-S2-O15 |
Ejemplares similares
-
MELD Score Kinetics in Decompensated HIV+/HCV+ Patients: A Useful Prognostic Tool (ANRS HC EP 25 PRETHEVIC Cohort Study)
por: Gelu-Simeon, Moana, et al.
Publicado: (2015) -
Coffee Intake and Neurocognitive Performance in HIV/HCV Coinfected Patients (ANRS CO13 HEPAVIH)
por: Antwerpes, Saskia, et al.
Publicado: (2020) -
Managing HCV/HIV coinfection
por: Danish, Fazal A., et al.
Publicado: (2009) -
Pharmacologic management of HCV treatment in patients with HCV monoinfection vs. HIV/HCV coinfection: Does coinfection really matter?
por: Zuckerman, Autumn D., et al.
Publicado: (2019) -
UDP-glucuronosyltransferase UGT1A7 genetic polymorphisms in hepatocellular carcinoma: a differential impact according to seropositivity of HBV or HCV markers?
por: Stücker, I, et al.
Publicado: (2007)